Sonoma Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $3,579 | $3,391 | $3,439 | $3,138 |
Gross Profit | 1,361 | 1,306 | 1,091 | 1,460 |
EBITDA | -815 | -1,134 | -1,368 | -799 |
EBIT | -850 | -1,173 | -1,409 | -844 |
Net Income | -610 | -1,143 | -1,067 | -866 |
Net Change In Cash | 3,579 | 3,391 | 3,439 | 3,138 |
Free Cash Flow | 328 | -917 | 155 | -1,105 |
Cash | 4,078 | 2,589 | 3,128 | 2,406 |
Basic Shares | 1,034 | 851 | 780 | 545 |
Annual Financials
| Values in thousands | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|
Revenue | $12,735 | $13,272 | $12,628 | $18,629 |
Gross Profit | 4,745 | 4,477 | 3,993 | 6,559 |
EBITDA | -4,525 | -4,445 | -5,701 | -3,222 |
EBIT | -4,701 | -4,743 | -6,110 | -3,449 |
Net Income | -4,835 | -5,151 | -5,086 | -4,615 |
Net Change In Cash | 12,735 | 13,272 | 12,628 | 18,629 |
Cost of Revenue | 529 | |||
Free Cash Flow | -2,415 | -6,421 | -4,385 | -3,557 |
Cash | 3,128 | 3,820 | 7,396 | 4,220 |
Basic Shares | 454 | 169 | 132 | 99 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.59 |
2024-06-30 | -$0.07 |
2024-03-31 | -$0.07 |
2023-12-31 | -$0.08 |
